Amgen Inc.

Amgen Inc. BDR
Stock Exchange Brazilian Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
-
Public Float
-
Amgen Inc.
Stock Exchange Xetra Stock Exchange
EPS
EUR10.83
Market Cap
EUR102.14 B
Shares Outstanding
661.71 M
Public Float
667.54 M
Amgen Inc.
Stock Exchange Mexican Stock Exchange
EPS
MXN242.71
Market Cap
MXN2.15 T
Shares Outstanding
661.71 M
Public Float
667.54 M
Amgen Inc.
Stock Exchange NASDAQ Stock Market
EPS
$12.54
Market Cap
$113.41 B
Shares Outstanding
609.94 M
Public Float
621.01 M

Profile

Address
One Amgen Center Drive
Thousand Oaks California 91320
United States
Employees -
Website http://www.amgen.com
Updated 07/08/2019
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K.

Financials

View All

Robert A. Bradway
Chairman & Chief Executive Officer
Brian Druker
Director